Rachael Zimlich, RN
Rachael Zimlich is a freelance writer in Cleveland, Ohio. She writes regularly for Contemporary Pediatrics, Managed Healthcare Executive, and Medical Economics.
FDA restricts opioid-containing cold medicines for children
New FDA restrictions on medications for children that contain codeine and other opioids aim to prevent cases of misuse, abuse, and overdose.
Latest RA Treatment Developments: What Health Execs Need to Know
Latest RA Treatment Developments: What Health Execs Need to Know
Biologics, early treatment, and lifestyle choices take the spotlight in rheumatoid arthritis advances.
New modeling addresses heart disease in childhood cancer survivors
New predictive models may identify and help childhood cancer survivors at a higher risk for ischemic heart disease and stroke.
PCPs fall short on making rehab referrals for COPD patients
Less than 10% of eligible COPD patients were referred to pulmonary rehabilitation programs, according to a new UK study.
New study links congenital lung variations to COPD
Long-thought to be primarily caused by smoking and other exposures, scientists now believe that congenital changes to lung tissues with a genetic link may also be to blame.
Can folic acid mitigate autism risk for kids with epileptic mothers?
A new study reveals that folic acid supplementation in mothers treated for epilepsy during pregnancy had children who were more likely to display autistic traits.
Is end-of-life care the place for big data?
Is end-of-life care the place for big data?
The benefits and drawbacks of predictive modeling in end-of-life care decision making.
New study urges clinicians to consider needle fears
Fear of needles may play a larger role than clinicians think in vaccine compliance, both in the childhood years and beyond.
Children still prescribed postop codeine despite warnings
A new study reveals that too many children are still given codeine or codeine-containing medications after surgery.
Hypertension higher in childhood cancer survivors
Adults who have survived childhood cancer are about 10 years ahead of their peers in terms of developing hypertension, according to a new report.


View Results